The outcomes affirm conclusions drawn by Bagli et al. [one], who conducted a research that incorporated ten patients diagnosed with CRAO who been given HBOT. As well as acquiring twenty classes of HBOT, oral acetazolamide and topical beta-blockers ended up administered on the patients at the earliest feasible time.Connect with or see your healthcar